Total Payments
$8,064
2024 Payments
$2,493
Companies
31
Transactions
390
Medicare Patients
2,339
Medicare Billing
$314,755
Payment Breakdown by Category
Food & Beverage$7,886 (97.8%)
Education$178.45 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,886 | 386 | 97.8% |
| Education | $178.45 | 4 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,501 | 109 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,301 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $918.25 | 42 | $0 (2024) |
| GENZYME CORPORATION | $835.67 | 45 | $0 (2024) |
| Insmed, Inc. | $447.29 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $409.41 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $235.21 | 12 | $0 (2024) |
| Amgen Inc. | $229.05 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $192.88 | 10 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $162.48 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,493 | 111 | AstraZeneca Pharmaceuticals LP ($867.59) |
| 2023 | $2,693 | 133 | AstraZeneca Pharmaceuticals LP ($917.09) |
| 2022 | $2,307 | 111 | AstraZeneca Pharmaceuticals LP ($645.56) |
| 2021 | $145.25 | 10 | AstraZeneca Pharmaceuticals LP ($42.68) |
| 2020 | $199.91 | 12 | GlaxoSmithKline, LLC. ($83.68) |
| 2019 | $150.93 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89.95) |
| 2018 | $37.26 | 2 | Circassia Pharmaceuticals Inc ($19.49) |
| 2017 | $38.56 | 2 | Pinnacle Biologics, Inc ($21.12) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Immunology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Immunology | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 634 | 797 | $189,170 | $76,159 |
| 2022 | 10 | 484 | 624 | $172,840 | $66,301 |
| 2021 | 13 | 554 | 771 | $234,145 | $82,468 |
| 2020 | 18 | 667 | 889 | $265,340 | $89,828 |
Total Patients
2,339
Total Services
3,081
Medicare Billing
$314,755
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 163 | $44,825 | $16,176 | 36.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 121 | $22,990 | $11,630 | 50.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 78 | $28,080 | $11,163 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $29,400 | $10,292 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 72 | $25,200 | $10,285 | 40.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 136 | $17,680 | $8,769 | 49.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,650 | $2,901 | 37.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,675 | $1,615 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,280 | $849.85 | 37.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 19 | $1,425 | $792.49 | 55.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 13 | 13 | $1,560 | $514.14 | 33.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 12 | $1,440 | $488.20 | 33.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $1,500 | $324.50 | 21.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 13 | 13 | $520.00 | $128.18 | 24.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 15 | 15 | $525.00 | $126.90 | 24.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 14 | 14 | $420.00 | $102.76 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 105 | $45,200 | $17,577 | 38.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 152 | $32,480 | $13,023 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $26,950 | $9,579 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 100 | 153 | $25,140 | $9,163 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 36 | $12,750 | $5,564 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 51 | $14,225 | $5,402 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,125 | $2,850 | 40.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $5,870 | $2,172 | 37.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 11 | 11 | $1,305 | $526.84 | 40.4% |
About Dr. Nicholas Hinds, M.D
Dr. Nicholas Hinds, M.D is a Pulmonary Disease healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1346689551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Hinds, M.D has received a total of $8,064 in payments from pharmaceutical and medical device companies, with $2,493 received in 2024. These payments were reported across 390 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,886).
As a Medicare-enrolled provider, Hinds has provided services to 2,339 Medicare beneficiaries, totaling 3,081 services with total Medicare billing of $314,755. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Allentown, PA
- Active Since 06/20/2013
- Last Updated 07/01/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1346689551
Products in Payments
- DUPIXENT (Biological) $1,325
- FASENRA (Biological) $1,196
- TRELEGY ELLIPTA (Drug) $911.42
- BREZTRI (Drug) $776.59
- TEZSPIRE (Biological) $549.63
- Arikayce (Drug) $447.29
- STIOLTO RESPIMAT (Drug) $390.67
- OFEV (Drug) $361.58
- NUCALA (Biological) $308.03
- GLASSIA (Biological) $190.25
- AIRSUPRA (Drug) $162.62
- XYWAV (Drug) $162.48
- WAKIX (Drug) $149.37
- YUPELRI (Drug) $111.42
- (8874) inCourage (Device) $98.08
- Yupelri (Drug) $81.46
- UPTRAVI (Drug) $63.62
- ARALAST (Biological) $59.30
- PURIFIED CORTROPHIN GEL (Drug) $47.65
- TYVASO (Drug) $42.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Allentown
Robert Kruklitis, Md, MD
Pulmonary Disease — Payments: $225,939
Pulmonary Disease $225,939
Satyasagar Morisetty, Md, MD
Pulmonary Disease — Payments: $12,829
Pulmonary Disease $12,829
C Petersen, Md, MD
Pulmonary Disease — Payments: $7,955
Pulmonary Disease $7,955
Scott Blumhof, D.o, D.O
Pulmonary Disease — Payments: $4,498
Pulmonary Disease $4,498
Dr. Aparna Kumar, Md, MD
Pulmonary Disease — Payments: $3,551
Pulmonary Disease $3,551
Matthew Mccambridge, Md, MD
Pulmonary Disease — Payments: $3,488
Pulmonary Disease $3,488